XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.20.2

Investments | 9 Months Ended
--- | ---
Sep. 30, 2020
Investments, Debt and Equity Securities [Abstract] |
Investments | Investments Fixed Maturities The amortized cost and estimated fair values of the Company’s Investments in Fixed Maturities at September 30, 2020 were:
|  | Amortized Cost |  | Gross Unrealized |  | Allowance for Expected Credit Losses |  | Fair Value
(Dollars in Millions) |  | Gains |  | Losses
U.S. Government and Government Agencies and Authorities |  | $ | 596.6 |  |  | $ | 56.2 |  |  | $ | — |  |  | $ | — |  |  | $ | 652.8 |
States and Political Subdivisions |  | 1,334.3 |  |  | 178.9 |  |  | (1.6) |  |  | — |  |  | 1,511.6 |
Foreign Governments |  | 6.7 |  |  | — |  |  | (1.2) |  |  | (0.6) |  |  | 4.9 |
Corporate Securities: |  |  |  |  |  |  |  |  |  |
Bonds and Notes |  | 3,786.8 |  |  | 611.6 |  |  | (18.5) |  |  | (4.2) |  |  | 4,375.7 |
Redeemable Preferred Stocks |  | 6.7 |  |  | 0.6 |  |  | — |  |  | — |  |  | 7.3 |
Collateralized Loan Obligations |  | 759.5 |  |  | 1.8 |  |  | (33.9) |  |  | — |  |  | 727.4 |
Other Mortgage- and Asset-backed |  | 204.2 |  |  | 20.9 |  |  | — |  |  | — |  |  | 225.1 |
Investments in Fixed Maturities |  | $ | 6,694.8 |  |  | $ | 870.0 |  |  | $ | (55.2) |  |  | $ | (4.8) |  |  | $ | 7,504.8 |
The amortized cost and estimated fair values of the Company’s Investments in Fixed Maturities at December 31, 2019 were:
|  | Amortized Cost |  | Gross Unrealized |  | Fair Value
(Dollars in Millions) |  | Gains |  | Losses |
U.S. Government and Government Agencies and Authorities |  | $ | 784.7 |  |  | $ | 32.5 |  |  | $ | (1.3) |  |  | $ | 815.9 |
States and Political Subdivisions |  | 1,386.4 |  |  | 130.5 |  |  | (1.1) |  |  | 1,515.8 |
Foreign Governments |  | 17.2 |  |  | 1.2 |  |  | (1.6) |  |  | 16.8 |
Corporate Securities: |  |  |  |  |  |  |  |
Bonds and Notes |  | 3,465.0 |  |  | 401.8 |  |  | (7.1) |  |  | 3,859.7 |
Redeemable Preferred Stocks |  | 6.8 |  |  | — |  |  | (0.1) |  |  | 6.7 |
Collateralized Loan Obligations |  | 624.6 |  |  | 2.1 |  |  | (8.5) |  |  | 618.2 |
Other Mortgage- and Asset-backed |  | 88.0 |  |  | 2.1 |  |  | (1.1) |  |  | 89.0 |
Investments in Fixed Maturities |  | $ | 6,372.7 |  |  | $ | 570.2 |  |  | $ | (20.8) |  |  | $ | 6,922.1 |
Other Receivables included $3.5 million and $1.0 million of unsettled sales of Investments in Fixed Maturities at September 30, 2020 and December 31, 2019, respectively. Accrued Expenses and Other Liabilities included unsettled purchases of Investments in Fixed Maturities of $29.8 million and $19.5 million at September 30, 2020 and December 31, 2019, respectively. Note 2 - Investments (continued) The amortized cost and estimated fair values of the Company’s Investments in Fixed Maturities at September 30, 2020 by contractual maturity were:
(Dollars in Millions) |  | Amortized Cost |  | Fair Value
Due in One Year or Less |  | $ | 122.6 |  |  | $ | 124.2 |
Due after One Year to Five Years |  | 1,060.5 |  |  | 1,117.0 |
Due after Five Years to Ten Years |  | 1,616.8 |  |  | 1,812.8 |
Due after Ten Years |  | 2,475.7 |  |  | 3,012.0 |
Mortgage- and Asset-backed Securities Not Due at a Single Maturity Date |  | 1,419.2 |  |  | 1,438.8 |
Investments in Fixed Maturities |  | $ | 6,694.8 |  |  | $ | 7,504.8 |
The expected maturities of the Company’s Investments in Fixed Maturities may differ from the contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties. Investments in Mortgage- and Asset-backed Securities Not Due at a Single Maturity Date at September 30, 2020 consisted of securities issued by the Government National Mortgage Association with a fair value of $469.7 million, securities issued by the Federal National Mortgage Association with a fair value of $5.7 million, securities issued by the Federal Home Loan Mortgage Corporation with a fair value of $12.5 million and securities of other non-governmental issuers with a fair value of $950.9 million. An aging of unrealized losses on the Company’s Investments in Fixed Maturities at September 30, 2020 is presented below.
|  | Less Than 12 Months |  | 12 Months or Longer |  | Total
(Dollars in Millions) |  | Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses
Fixed Maturities: |  |  |  |  |  |  |  |  |  |  |  |
U.S. Government and Government Agencies and Authorities |  | $ | 2.3 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 2.3 |  |  | $ | — |
States and Political Subdivisions |  | 28.5 |  |  | (1.6) |  |  | — |  |  | — |  |  | 28.5 |  |  | (1.6) |
Foreign Governments |  | 2.5 |  |  | (0.2) |  |  | 2.4 |  |  | (1.0) |  |  | 4.9 |  |  | (1.2) |
Corporate Securities: |  |  |  |  |  |  |  |  |  |  |  |
Bonds and Notes |  | 336.2 |  |  | (15.5) |  |  | 24.7 |  |  | (3.0) |  |  | 360.9 |  |  | (18.5) |
Collateralized Loan Obligations |  | 276.4 |  |  | (11.6) |  |  | 321.0 |  |  | (22.3) |  |  | 597.4 |  |  | (33.9) |
Other Mortgage- and Asset-backed |  | 1.4 |  |  | — |  |  | — |  |  | — |  |  | 1.4 |  |  | — |
Total Fixed Maturities |  | $ | 647.3 |  |  | $ | (28.9) |  |  | $ | 348.1 |  |  | $ | (26.3) |  |  | $ | 995.4 |  |  | $ | (55.2) |
At September 30, 2020, the Company did not have the intent to sell these investments, and it was not more likely than not that the Company would be required to sell these investments before an anticipated recovery of value. The Company evaluated these investments for credit losses at September 30, 2020. The Company considers many factors in evaluating whether the unrealized losses were credit related including, but not limited to, the extent to which the fair value has been less than amortized cost, conditions related to the security, industry, or geographic area, payment structure of the investment and the likelihood of the issuer’s ability to make contractual cashflows, defaults or other collectability concerns related to the issuer, changes in the ratings assigned by a rating agency, and other credit enhancements that affect the investment’s expected performance. The Company determined that the unrealized losses on these securities were due to non-credit related factors at the evaluation date. Investment-grade fixed maturity investments comprised $19.2 million and below-investment-grade fixed maturity investments comprised $36.0 million of the unrealized losses on investments in fixed maturities at September 30, 2020. For below-investment-grade fixed maturity investments in an unrealized loss position, the unrealized loss amount, on average, was approximately 11% of the amortized cost basis of the investment. Note 2 - Investments (continued) An aging of unrealized losses on the Company’s Investments in Fixed Maturities at December 31, 2019 is presented below.
|  | Less Than 12 Months |  | 12 Months or Longer |  | Total
(Dollars in Millions) |  | Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses |  | Fair Value |  | Unrealized Losses
Fixed Maturities: |  |  |  |  |  |  |  |  |  |  |  |
U.S. Government and Government Agencies and Authorities |  | $ | 118.5 |  |  | $ | (1.3) |  |  | $ | 5.1 |  |  | $ | — |  |  | $ | 123.6 |  |  | $ | (1.3) |
States and Political Subdivisions |  | 63.0 |  |  | (0.7) |  |  | 5.4 |  |  | (0.4) |  |  | 68.4 |  |  | (1.1) |
Foreign Governments |  | 1.0 |  |  | (0.3) |  |  | 3.1 |  |  | (1.3) |  |  | 4.1 |  |  | (1.6) |
Corporate Securities: |  |  |  |  |  |  |  |  |  |  |  |
Bonds and Notes |  | 160.0 |  |  | (2.1) |  |  | 70.7 |  |  | (5.0) |  |  | 230.7 |  |  | (7.1) |
Redeemable Preferred Stocks |  | 5.5 |  |  | (0.1) |  |  | — |  |  | — |  |  | 5.5 |  |  | (0.1) |
Collateralized Loan Obligations |  | 95.5 |  |  | (1.9) |  |  | 355.6 |  |  | (6.6) |  |  | 451.1 |  |  | (8.5) |
Other Mortgage- and Asset-backed |  | 72.8 |  |  | (1.1) |  |  | — |  |  | — |  |  | 72.8 |  |  | (1.1) |
Total Fixed Maturities |  | $ | 516.3 |  |  | $ | (7.5) |  |  | $ | 439.9 |  |  | $ | (13.3) |  |  | $ | 956.2 |  |  | $ | (20.8) |
Based on the Company’s evaluation at December 31, 2019 of the prospects of the issuers, including, but not limited to, the credit ratings of the issuers of the investments in the fixed maturities, and the Company’s intention to not sell and its determination that it would not be required to sell before recovery of the amortized cost of such investments, the Company concluded that the declines in the fair values of the Company’s investments in fixed maturities presented in the preceding table were temporary at the evaluation date. Investment-grade fixed maturity investments comprised $9.1 million and below-investment-grade fixed maturity investments comprised $11.7 million of the unrealized losses on investments in fixed maturities at December 31, 2019. For below-investment-grade fixed maturity investments in an unrealized loss position, the unrealized loss amount, on average, was approximately 5% of the amortized cost basis of the investment. At December 31, 2019, the Company did not have the intent to sell these investments, and it was not more likely than not that the Company would be required to sell these investments before recovery of its amortized cost basis, which may be at maturity. There were $0.3 million unrealized losses at December 31, 2019 related to securities for which the Company has recognized credit losses in earnings in the preceding table under the heading “Less Than 12 Months.” There were no unrealized losses at December 31, 2019 related to securities for which the Company has recognized credit losses in earnings in the preceding table under the heading “12 Months or Longer.” Fixed Maturities - Impairment Losses The following table sets forth the change in allowance for credit losses on fixed maturities available-for-sale by major security type for nine months ended September 30, 2020.
|  |  |  | Foreign Governments |  | Corporate Bonds and Notes |  |  |  | Total
(Dollars in Millions)
Allowance for Credit Losses at Beginning of the Year |  |  |  | $ | — |  |  | $ | — |  |  |  |  | $ | — |
Impact of Adopting ASU 2016-13 |  |  |  | — |  |  | — |  |  |  |  | — |
Additions for Securities for which No Previous Expected Credit Losses were Recognized |  |  |  | 0.6 |  |  | 5.0 |  |  |  |  | 5.6 |
Reduction Due to Sales |  |  |  | (0.1) |  |  | (0.4) |  |  |  |  | (0.5) |
Net Increase (Decrease) in Allowance on Previously Impaired Securities |  |  |  | 0.1 |  |  | (0.1) |  |  |  |  | — |
Write-offs Charged Against Allowance |  |  |  | — |  |  | (0.3) |  |  |  |  | (0.3) |
Allowance for Credit Losses at End of Period |  |  |  | $ | 0.6 |  |  | $ | 4.2 |  |  |  |  | $ | 4.8 |
Note 2 - Investments (continued) The following table sets forth the change in allowance for credit losses on fixed maturities available-for-sale by major security type for the three months ended September 30, 2020.
|  |  |  | Foreign Governments |  | Corporate Bonds and Notes |  |  |  | Total
(Dollars in Millions)
Allowance for Credit Losses at Beginning of the Period |  |  |  | $ | 0.6 |  |  | $ | 4.8 |  |  |  |  | $ | 5.4 |
Additions for Securities for which No Previous Expected Credit Losses were Recognized |  |  |  | — |  |  | 0.2 |  |  |  |  | 0.2 |
Reduction Due to Sales |  |  |  | (0.1) |  |  | (0.4) |  |  |  |  | (0.5) |
Net Increase (Decrease) in Allowance on Previously Impaired Securities |  |  |  | 0.1 |  |  | (0.1) |  |  |  |  | — |
Write-offs Charged Against Allowance |  |  |  | — |  |  | (0.3) |  |  |  |  | (0.3) |
Allowance for Credit Losses at End of Period |  |  |  | $ | 0.6 |  |  | $ | 4.2 |  |  |  |  | $ | 4.8 |
Equity Securities Investments in Equity Securities at Fair Value were $788.2 million and $907.3 million at September 30, 2020 and December 31, 2019, respectively. Net unrealized gains arising during the nine months ended September 30, 2020 and recognized in earnings, related to such investments still held as of September 30, 2020, were $76.7 million. For Equity Securities at Modified Cost, the Company performs a qualitative impairment analysis on a quarterly basis consisting of various factors such as earnings performance, current market conditions, changes in credit ratings, changes in the regulatory environment and other factors. If the qualitative analysis identifies the presence of impairment indicators, the Company estimates the fair value of the investment. If the estimated fair value is below the carrying value, the Company records an impairment in the Condensed Consolidated Statement of Income to reduce the carrying value to the estimated fair value. When the Company identifies observable transactions of the same or similar securities to those held by the Company, the Company increases or decreases the carrying value to the observable transaction price. The Company did not recognize any increases in the carrying value due to observable transactions for the nine months ended September 30, 2020. The Company recognized an impairment of $2.0 million on Equity Securities at Modified Cost for the nine months ended September 30, 2020 as a result of the Company’s qualitative impairment analysis. The Company has recognized $0.5 million cumulative decreases in the carrying value due to observable transactions, no cumulative increases in the carrying value due to observable transactions and $5.0 million of cumulative impairments on Equity Securities at Modified Cost held as of September 30, 2020. There were no unsettled sales of Investments in Equity Securities at September 30, 2020 and December 31, 2019. There were no unsettled purchases of Investments in Equity Securities at September 30, 2020 and December 31, 2019. Equity Method Limited Liability Investments at Cost Plus Cumulative Undistributed Earnings Equity Method Limited Liability Investments include investments in limited liability investment companies and limited partnerships in which the Company’s interests are not deemed minor and are accounted for under the equity method of accounting. The Company’s investments in Equity Method Limited Liability Investments are generally of a passive nature in that the Company does not take an active role in the management of the investment entity. The Company’s maximum exposure to loss at September 30, 2020 is limited to the total carrying value of $206.2 million. In addition, the Company had outstanding commitments totaling approximately $96.5 million to fund Equity Method Limited Liability Investments at September 30, 2020. At September 30, 2020, 4.4% of Equity Method Limited Liability Investments were reported without a reporting lag. 8.0% of the total carrying value were reported with a one month lag and the remainder were reported with more than a one month lag. Note 2 - Investments (continued) Other Investments The carrying values of the Company’s Other Investments at September 30, 2020 and December 31, 2019 were:
(Dollars in Millions) |  | Sep 30, 2020 |  | Dec 31, 2019
Company-owned Life Insurance |  | $ | 326.1 |  |  | $ | 217.0 |
Loans to Policyholders at Unpaid Principal |  | 299.5 |  |  | 305.6 |
Real Estate at Depreciated Cost |  | 99.6 |  |  | 111.4 |
Mortgage Loans and Other |  | 37.6 |  |  | 27.5 |
Total |  | $ | 762.8 |  |  | $ | 661.5 |
Net Investment Income Net Investment Income for the nine and three months ended September 30, 2020 and 2019 was:
|  | Nine Months Ended |  | Three Months Ended
(Dollars in Millions) |  | Sep 30, 2020 |  | Sep 30, 2019 |  | Sep 30, 2020 |  | Sep 30, 2019
Investment Income (Loss): |  |  |  |  |  |  |  |
Interest on Fixed Income Securities |  | $ | 218.0 |  |  | $ | 225.5 |  |  | $ | 72.7 |  |  | $ | 73.5 |
Dividends on Equity Securities Excluding Alternative Investments |  | 10.7 |  |  | 14.6 |  |  | 2.8 |  |  | 5.2 |
Alternative Investments: |  |  |  |  |  |  |  |
Equity Method Limited Liability Investments |  | (2.7) |  |  | 0.6 |  |  | 8.2 |  |  | 1.6 |
Limited Liability Investments Included in Equity Securities |  | 7.3 |  |  | 12.9 |  |  | 2.4 |  |  | 5.2 |
Total Alternative Investments |  | 4.6 |  |  | 13.5 |  |  | 10.6 |  |  | 6.8 |
Short-term Investments |  | 4.2 |  |  | 6.9 |  |  | 2.3 |  |  | 2.5 |
Loans to Policyholders |  | 16.6 |  |  | 16.9 |  |  | 5.5 |  |  | 5.9 |
Real Estate |  | 7.1 |  |  | 7.1 |  |  | 2.3 |  |  | 2.4 |
Other |  | 9.3 |  |  | 0.9 |  |  | 2.7 |  |  | 0.6 |
Total Investment Income |  | 270.5 |  |  | 285.4 |  |  | 98.9 |  |  | 96.9 |
Investment Expenses: |  |  |  |  |  |  |  |
Real Estate |  | 6.5 |  |  | 7.2 |  |  | 1.2 |  |  | 2.5 |
Other Investment Expenses |  | 18.5 |  |  | 7.8 |  |  | 5.6 |  |  | 2.7 |
Total Investment Expenses |  | 25.0 |  |  | 15.0 |  |  | 6.8 |  |  | 5.2 |
Net Investment Income |  | $ | 245.5 |  |  | $ | 270.4 |  |  | $ | 92.1 |  |  | $ | 91.7 |
Gross gains and losses on sales of investments in fixed maturities for the nine and three months ended September 30, 2020 and 2019 were:
|  | Nine Months Ended |  | Three Months Ended
(Dollars in Millions) |  | Sep 30, 2020 |  | Sep 30, 2019 |  | Sep 30, 2020 |  | Sep 30, 2019
Fixed Maturities: |  |  |  |  |  |  |  |
Gains on Sales |  | $ | 38.7 |  |  | $ | 39.7 |  |  | $ | 11.9 |  |  | $ | 1.9 |
Losses on Sales |  | (3.5) |  |  | (4.8) |  |  | (1.9) |  |  | (0.3) |

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2209399 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2324412 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 940 -SubTopic 320 -URI http://asc.fasb.org/subtopic&trid=2176304 + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration